Casdin Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.08M | Buy |
650,000
+15,000
| +2% | +$140K | 0.55% | 20 |
|
|
2025
Q1 | $7.8M | Buy |
635,000
+160,000
| +34% | +$1.97M | 0.64% | 25 |
|
|
2024
Q4 | $6.28M | Hold |
475,000
| – | – | 0.42% | 26 |
|
|
2024
Q3 | $9.14M | Buy |
475,000
+325,000
| +217% | +$6.26M | 0.61% | 24 |
|
|
2024
Q2 | $3.08M | Hold |
150,000
| – | – | 0.24% | 28 |
|
|
2024
Q1 | $3.57M | Hold |
150,000
| – | – | 0.27% | 31 |
|
|
2023
Q4 | $3.24M | Buy |
+150,000
| New | +$3.24M | 0.32% | 30 |
|
|
2021
Q4 | – | Sell |
-1,200,000
| Closed | -$22.9M | – | 56 |
|
|
2021
Q3 | $22.9M | Hold |
1,200,000
| – | – | 0.57% | 37 |
|
|
2021
Q2 | $20.6M | Buy |
1,200,000
+200,000
| +20% | +$3.43M | 0.52% | 36 |
|
|
2021
Q1 | $22.4M | Buy |
1,000,000
+550,000
| +122% | +$12.3M | 0.67% | 31 |
|
|
2020
Q4 | $10M | Buy |
+450,000
| New | +$10M | 0.3% | 40 |
|